Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesHomocysteine as a predictor of cognitive decline in Alzheimers disease
International Journal of Geriatric Psychiatry, 06/02/09
Oulhaj A et al. - Raised homocysteine concentrations within the normal range among the elderly strongly relate to the rate of global cognitive decline in patients with Alzheimer disease. Plasma homocysteine can readily be lowered by B-vitamin treatment and trials should be carried out to see if such treatments can slow the rate of cognitive decline in relatively young patients with Alzheimer disease.
Methods- In 97 patients with AD, 73 pathologically-confirmed,
- This study analysed the decline of global cognitive test scores (CAMCOG) over time from the first assessment for at least three 6-monthly visits up to a maximum of 9.5 years (in total 689 assessments). Non-linear mixed-effects statistical models were used.
- Baseline homocysteine levels showed a concentration-response relationship with the subsequent rate of decline in CAMCOG scores: the higher the homocysteine, the faster the decline.
- The relationship was significant in patients aged < 75 years who had not suffered a prior stroke.
- For example, in patients aged 65 years with a baseline homocysteine of 14 µmol/L, the decline from a CAMCOG score of 88 to a score of 44 occurred 19.2 (95% CI 6.8, 31.6) months earlier than in patients with a baseline homocysteine of 10 µmol/L.
A. David Smith, 06/03/09
| The findings have two main clinical implications: first, a high baseline homocysteine level can be used to predict that a patient is likely to decline more rapidly; second, since homocysteine levels can be lowered by B vitamin treatment, trials should be initiated on Alzheimer patients who are aged less than 75 to see if lowering homocysteine can slow disease progression. Whether or not high homocysteine is causal, it is certainly a good prognostic marker. |
Related Articles
Elevated Homocysteine Is a Predictor of All-Cause Mortality in a Prospective Cohort of Renal Transplant Recipients
Nephron: Clinical Practice, 10/01/09
Relevance Score: 82%
The association between high plasma homocysteine levels and lower bone mineral density in Slovak women: the impact of vegetarian diet
European Journal of Nutrition, 10/12/09
Relevance Score: 80%
Etiology and predictors of urinary incontinence and its effect on quality of life
Geriatrics and Gerontology International, 11/17/09
Relevance Score: 79%
Aging Changes Could Predict Future Alzheimers
Internet Source, 10/16/09
Relevance Score: 79%
A Prospective Study on the Development of Alzheimer's Disease with Regard to Thyroid-Stimulating Hormone and Homocysteine
Dementia and Geriatric Cognitive Disorders, 10/01/09
Relevance Score: 79%
Today in Geriatric Psych...keeping you current
Receive free subspecialty "5-minute updates" via email
Suicidal thoughts and depressive feelings amongst Estonian schoolchildren: effect of family relationship and family structure
European Child and Adolescent Psychiatry, 12/08/09
Community Integration and Associated Factors Among Older Adults With Schizophrenia
Psychiatric Services, 12/08/09
Primary care and dementia: 2. long-term care at home: psychosocial interventions, information provision, carer support and case management
International Journal of Geriatric Psychiatry, 12/07/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Sleep problems as reported by parents in Swedish children and adolescents with obsessive-compulsive disorder (OCD), child psychiatric outpatients and school children
Nordic Journal of Psychiatry, 12/10/09
Screening of psychiatric outpatients for borderline personality disorder with the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD)
Nordic Journal of Psychiatry, 12/10/09
Is pregnancy associated with mood and anxiety disorders? A cross-sectional study
General Hospital Psychiatry, 12/09/09
Today in Personality Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Sleep problems as reported by parents in Swedish children and adolescents with obsessive-compulsive disorder (OCD), child psychiatric outpatients and school children
Nordic Journal of Psychiatry, 12/10/09
Screening of psychiatric outpatients for borderline personality disorder with the McLean Screening Instrument for Borderline Personality Disorder (MSI-BPD)
Nordic Journal of Psychiatry, 12/10/09
A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder
Acta Psychiatrica Scandinavica, 12/08/09
Today in Substance Abuse...keeping you current
Receive free subspecialty "5-minute updates" via email
Suboxone (Buprenorphine/Naloxone) as an Agonist Opioid Treatment in Spain: A Budgetary Impact Analysis
European Addiction Research, 12/08/09
Perceived Need for Treatment for Alcohol Use Disorders: Results From Two National Surveys
Psychiatric Services, 12/08/09
Psychosocial Correlates of Insomnia in An Adolescent Population
Child Psychiatry and Human Development, 12/07/09
Sponsor
Article Search
Sponsor